Drug Profile
Cancer vaccine - Ferring Pharmaceuticals
Alternative Names: FibrovaxLatest Information Update: 31 Dec 2021
Price :
$50
*
At a glance
- Originator Cytokine PharmaSciences
- Class Cancer vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 03 Sep 2012 No development reported - Phase-I for Cancer in USA (Injection)
- 18 Jul 2000 Cytokine Networks is now called Cytokine PharmaSciences
- 27 Apr 1998 New profile